Alkermes ALKS
NASDAQ ALKS
$45.43 -0.06 (-0.13%)
As of: Sep 9, 2026 · 1:23 PM EDT

Alkermes (ALKS) Accounts Payables (2011 - 2026)

Alkermes' (ALKS) quarterly Accounts Payables came in at $332.5 million in Q2 2026, up 35.29% year-over-year from $245.7 million in Q2 2025, and up 13.63% quarter-over-quarter from $292.6 million in Q1 2026.

Analysis

Alkermes (ALKS) Accounts Payables (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Accounts Payables for 16 consecutive years, with $332.5 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Accounts Payables rose 35.29% year-over-year to $332.5 million in Q2 2026; TTM through Jun 2026 was $332.5 million, a 35.29% increase from a year earlier, with the FY2025 full-year figure at $289.6 million, up 56.24% from the prior year.
  • Accounts Payables was $332.5 million for Q2 2026 at Alkermes, up from $292.6 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $332.5 million in Q2 2026 and troughed at $160.2 million in Q3 2024.
  • A 5-year average of $225.6 million and a median of $217.5 million in 2022 frame the typical range for Accounts Payables.
  • Across the five-year window, Accounts Payables plunged 50.66% in 2022 and soared 57.27% in 2026, its largest moves.
  • Over 5 years, Accounts Payables stood at $220.1 million in 2022, then increased by 9.3% to $240.6 million in 2023, then dropped by 22.96% to $185.3 million in 2024, then jumped by 56.24% to $289.6 million in 2025, then advanced by 14.82% to $332.5 million in 2026.
  • The last three Accounts Payables figures came in at $332.5 million (Q2 2026), $292.6 million (Q1 2026), and $289.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 644.32 Bn 623.56 Bn 17.26 Bn 9.22 Bn
2 AbbVie 440.60 Bn 434.04 Bn 12.70 Bn 33.30 Bn
3 Merck 365.39 Bn 358.25 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 4.26 Bn
5 Pfizer 159.22 Bn 147.52 Bn 10.94 Bn 4.58 Bn
6 Sanofi 52.48 Bn 45.10 Bn 10.79 Bn 8.31 Bn
7 Revolution Medicines 44.21 Bn 44.21 Bn - 88.42 Mn
8 Incyte 25.34 Bn 20.81 Bn 1.57 Bn 250.40 Mn
9 United Therapeutics 21.49 Bn 18.82 Bn 683.80 Mn 497.80 Mn
10 Alkermes 7.58 Bn 6.93 Bn 397.90 Mn 332.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 332.47 Mn
Mar 31, 2026 292.58 Mn
Dec 31, 2025 289.57 Mn
Sep 30, 2025 214.99 Mn
Jun 30, 2025 245.75 Mn
Mar 31, 2025 186.04 Mn
Dec 31, 2024 185.33 Mn
Sep 30, 2024 160.20 Mn
Jun 30, 2024 239.77 Mn
Mar 31, 2024 205.85 Mn
Dec 31, 2023 240.56 Mn
Sep 30, 2023 243.26 Mn
Jun 30, 2023 242.92 Mn
Mar 31, 2023 190.15 Mn
Dec 31, 2022 220.09 Mn
Sep 30, 2022 211.18 Mn
Jun 30, 2022 186.81 Mn
Mar 31, 2022 173.13 Mn
Dec 31, 2021 208.49 Mn
Sep 30, 2021 428.03 Mn